期刊文献+

自噬在非酒精性脂肪性肝病发生发展中的作用

Role of autophagy in the occurrence and development of Non-alcoholic fatty liver disease
下载PDF
导出
摘要 非酒精性脂肪性肝病(NAFLD)是以弥漫性肝细胞脂肪变性为主要特征的临床病理综合征,包括单纯性脂肪性肝病以及由其演变的脂肪性肝炎、脂肪性肝纤维化和肝硬化。原有的“两次打击”学说不能完全解释其发病机制,涉及多种因素的多重打击学说提供了更全面的描述,包括脂质毒性、炎症反应、纤维化和基因表达改变。自噬是溶酶体对胞浆成分降解的一种代谢途径。自噬参与该病多种发病机制,导致细胞脂质堆积、炎症反应和纤维化。本篇综述总结了Unc-51样自噬激活激酶1、腺苷酸激活蛋白酶、哺乳动物雷帕霉素复合物1与自噬的关系,并详细描述了自噬如何参与非酒精性脂肪性肝病的发生发展。 Non-alcoholic fatty liver disease(NAFLD)is a clinicopathological syndrome characterized by diffuse hepatocyte steatosis,including simple fatty liver disease and its evolution of steatohepatitis,fatty liver fibrosis and cirrhosis.The original"two-blow"theory cannot fully explain its pathogenesis,and the multiple-blow theory involving a variety of factors provides a more comprehensive description,including lipid toxicity,inflammation,fibrosis and changes in gene expression.Autophagy is a metabolic pathway for lysosome to degrade cytoplasmic components,which is involved in a variety of pathogenesis of the disease,leading to cellular lipid accumulation,inflammation and fibrosis.This review summarizes the relationship between Unc-51 like autophagy activating kinase 1(ULK1),AMP-activated protein kinase(AMPK),mammalian target of rapamycin complex 1(mTORC1)and autophagy,and describes in detail how autophagy participates in the occurrence and development of non-alcoholic fatty liver disease.
作者 杨施蔚(综述) 李明意(审校) YANG Shi-wei;LI Ming-yi(Department of Hepatobiliary Surgery,the Affiliated Hospital of Guangdong Medical University,Zhanjiang 524000,Guangdong,CHINA)
出处 《海南医学》 CAS 2020年第22期2971-2974,共4页 Hainan Medical Journal
关键词 非酒精性脂肪性肝病 自噬 Unc-51样自噬激活激酶1 腺苷酸激活蛋白酶 哺乳动物雷帕霉素复合物1 Non-alcoholic fatty liver disease(NAFLD) Autophagy Unc-51 like autophagy activating kinase 1(ULK1) AMP-activated protein kinase(AMPK) Mammalian target of rapamycin complex 1(mTORC1)
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部